Please wait patiently and don't refresh page as we are operating large database.

Issuer Name: Unicycive Therapeutics Inc. State/Country: CALIFORNIA IPO: 2021 CIK: 1766140
Industry: pharmaceuticals Sector: health care Fiscal Year End: Dec 31 unicycive.com

Institutional Sentiment ?

Period:2024-09-30

C: 22 / 7
S: 35.29 M / 7.45 M

Period:2024-06-30

C: 11 / 11
S: 1.00 M / 3.25 M
Holding Shares: 54.39 Mil (Pct:58.0% 3M:36.0% 1Yr:44.0%) Institutions reported:? 30/25 (Acq:73% Dis:0% Res:26% Sold out:23%) SC 13g/13d:? 3M:7(mktqtl:1.0) 6M:7(mktqtl:1.0)
Industry Quantile: 48.0% (3M:16.0% 1Yr:21.0%) Sector Quantile: 46.0% (3M:16.0% 1Yr:22.0%) Market Quantile: 44.0% (3M:16.0% 1Yr:22.0%)
FIGI ID: BBG01163JG34

(13F reporting period:2024-09-30    Data last updated 2024-11-27 07:31:43 -0600 US CDT


Notes: Data summarized from Form 13F/13G/13D reports filed to the SEC.
Data is updated daily between 5am and 7am CDT (except holidays).
Corrections were automatically applied to holding values where per share price obviously deviates from market median.


Details of Holding Changes & Schedule 13G/D Filings

COMMON STOCK    CSV download    

Filing Date Institution Operationa Reporting Period(last) Shares(last) Reporting Period Shares Value$1000 USD Holding Change%b Portfolio%c
2024-11-20 VIRTU FINANCIAL LLC Acquire 2024-06-30 11094 2024-09-30 73975 30000 566.8% 0.01%
2024-11-15 JANE STREET GROUP, LLC Acquire 2024-09-30 41249 16826 100.0% 0.0%
2024-11-14 SILVERARC CAPITAL MANAGEMENT, LLC Acquire 2024-09-30 4000000 1631600 100.0% 1.6%
2024-11-14 CAPTRUST FINANCIAL ADVISORS Restatement 2024-06-30 18800 2024-09-30 18800 7669 0.0% 0.01%
2024-11-14 NANTAHALA CAPITAL MANAGEMENT, LLC Restatement 2024-06-30 2820358 2024-09-30 2820358 1150424 0.0% 0.23%
2024-11-14 TOWER RESEARCH CAPITAL LLC Acquire 2024-06-30 18485 2024-09-30 22782 9295 23.25% 0.02%
2024-11-14 ACUTA CAPITAL PARTNERS, LLC Acquire 2024-09-30 1979199 807315 100.0% 3.42%
2024-11-14 LOGOS GLOBAL MANAGEMENT LP Acquire 2024-06-30 3469927 2024-09-30 5078927 2071694 46.37% 1.8%
2024-11-14 GOLDMAN SACHS GROUP INC Acquire 2024-06-30 93352 2024-09-30 93424 38108 0.08% 0.0%
2024-11-14 ALYESKA INVESTMENT GROUP, L.P. Acquire 2024-09-30 2250000 917775 100.0% 0.39%
2024-11-14 ALTIUM CAPITAL MANAGEMENT LP Acquire 2024-09-30 1473000 600837 100.0% 1.01%
2024-11-14 XTX TOPCO LTD Acquire 2024-09-30 70784 28873 100.0% 0.02%
2024-11-14 STATE STREET CORP Restatement 2024-06-30 43936 2024-09-30 43936 17921 0.0% 0.0%
2024-11-14 OCTAGON CAPITAL ADVISORS LP Acquire 2024-09-30 8559000 3491216 100.0% 2.99%
2024-11-14 WALLEYE CAPITAL LLC Acquire 2024-09-30 5000000 2039500 100.0% 0.17%
2024-11-14 TWO SIGMA SECURITIES, LLC Acquire 2024-09-30 23266 9490 100.0% 0.02%
2024-11-13 VANGUARD GROUP INC Restatement 2024-06-30 1138220 2024-09-30 1138220 464394 0.0% 0.02%
2024-11-13 BLACKROCK, INC. Acquire 2024-09-30 71821 29296 100.0% 0.0%
2024-11-13 GREAT POINT PARTNERS LLC Acquire 2024-09-30 8559000 3491216 100.0% 4.97%
2024-11-13 VIVO CAPITAL, LLC Acquire 2024-06-30 3470152 2024-09-30 4470152 1823375 28.82% 0.73%
2024-11-13 NORTHERN TRUST CORP Restatement 2024-06-30 23998 2024-09-30 23998 9789 0.0% 0.0%
2024-11-12 GEODE CAPITAL MANAGEMENT, LLC Acquire 2024-06-30 285738 2024-09-30 402398 164138 40.83% 0.01%
2024-11-08 LPL FINANCIAL LLC Acquire 2024-06-30 85000 2024-09-30 466005 190083 448.24% 0.03%
2024-10-23 TANDEM CAPITAL MANAGEMENT CORP /ADV Restatement 2024-06-30 15500 2024-09-30 15500 21390 0.0% 1.45%
2024-10-16 BLEAKLEY FINANCIAL GROUP, LLC Acquire 2024-09-30 80000 32632 100.0% 0.23%
2024-10-11 CREATIVE PLANNING Acquire 2024-09-30 10231 4173 100.0% 0.0%
2024-08-15 CAPTRUST FINANCIAL ADVISORS Restatement 2024-03-31 18800 2024-06-30 18800 9421 0.0% 0.01%
2024-08-14 RA CAPITAL MANAGEMENT, L.P. Dispose 2024-03-31 3470688 2024-06-30 2632200 1318995 -24.15% 0.11%
2024-08-14 STATE STREET CORP Acquire 2024-03-31 35036 2024-06-30 43936 22016 25.4% 0.0%
2024-08-14 SCIENTECH RESEARCH LLC Acquire 2024-06-30 10969 5497 100.0% 0.05%

aHolding share amount reported in current period compare to previous period (or compare to the same period if it is an amendment filing). Values can be "Acquire", "Dispose", "Restatement", "Restatement(+)","Restatement(-)". "Restatement(+)/(-)" stands for modification (increase/decrease) to the same period that has been reported before.
b(Current Holding shares - Last or same period holding shares) / Last or same period holding shares x 100%. The value is 100% for records without last period of holding.
cThe percentage of holding value relative to portfolio total.
Note: values subject to change as new filings become available.

COMMON STOCK    CSV download     realign column header

Filing Date Required Datea Filing Type Institution Issuer Name Aggregate Amount Pct Shrs Os (%) Sole Vtg Pow Shrd Vtg Pow Sole Dsp Pow Shrd Dsp Pow Shared Entityb Latest 13F Periodc Latest 13F Holdingd Operatione File Link
2024-11-14 2024-09-30 SC 13G/A GREAT POINT PARTNERS LLC UNICYCIVE THERAPEUTICS, INC. 9522432 10.0 0 9522432 0 9522432 3 2024-09-30 8559000 acq Link
2024-11-14 2024-09-30 SC 13G/A RA CAPITAL MANAGEMENT, L.P. UNICYCIVE THERAPEUTICS, INC. 10472375 10.0 0 10472375 0 10472375 4 2024-06-30 2632200 acq Link
2024-11-14 2024-09-30 SC 13G/A LOGOS GLOBAL MANAGEMENT LP UNICYCIVE THERAPEUTICS, INC. 5078927 4.9 0 5078927 0 5078927 5 2024-09-30 5078927 no change Link
2024-11-13 2024-09-30 SC 13G WALLEYE CAPITAL LLC UNICYCIVE THERAPEUTICS, INC. 5000000 5.3 5000000 0 5000000 0 1 2024-09-30 5000000 no change Link
2024-10-11 2024-09-30 SC 13G OCTAGON CAPITAL ADVISORS LP UNICYCIVE THERAPEUTICS, INC. 8559000 9.1 0 8559000 0 8559000 2 2024-09-30 8559000 no change Link
2024-10-11 2024-09-30 SC 13G OCTAGON CAPITAL ADVISORS LP UNICYCIVE THERAPEUTICS, INC. 5563000 5.9 0 5563000 0 5563000 1 - - - Link
2024-10-11 2024-09-30 SC 13G OCTAGON CAPITAL ADVISORS LP UNICYCIVE THERAPEUTICS, INC. 2996000 3.2 0 2996000 0 2996000 1 - - - Link
2024-02-14 2023-12-31 SC 13G/A RA CAPITAL MANAGEMENT, L.P. UNICYCIVE THERAPEUTICS, INC. 3472106 10.0 0 3472106 0 3472106 4 2023-12-31 3470688 acq Link
2024-02-14 2023-12-31 SC 13G/A NANTAHALA CAPITAL MANAGEMENT, LLC UNICYCIVE THERAPEUTICS, INC. 3475713 9.9 0 3475713 0 3475713 3 2023-12-31 3438181 acq Link

aDate of event which requires filing of this statement.
bThe number of entities that have exactly the same sole/shared voting/disposition power in the same 13G form.
cThe closest 13F filing period on or before the required date.
dThe holding shares reported in the closest 13F filing period on or before the required date.
eThe aggregated amount of shares reported in the 13G filing compare to the holding shares reported in the closest 13F filing (if any).
Note: The latest 13F holding shares and operation (as explained in superscript d and e, respectively) are for reference only, and subject to changes as new 13F filings become available. For a single 13G filing, only the largest aggregated amount is compared with 13F holding shares, others records (if any) are not compared and shown as short dash "-". When no 13F holding records were found, lastest 13F period/holding columns are blank.

Show up to 30 records per table for current tier. Download CSV to view up to 3000 records (Tier 1 and above. Access Guide)